Why is Natraj Proteins falling/rising?
2025-11-18 21:47:47As of 18-Nov, Natraj Proteins Ltd is experiencing a decline in its stock price, currently at 37.50, reflecting a decrease of 0.5, or 1.32%. The stock has been underperforming, having fallen consecutively for the last four days, resulting in a total decline of 5.99% during this period. Additionally, it is trading below all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages. In terms of performance against benchmarks, the stock has shown a significant decline of 15.92% year-to-date, while the Sensex has increased by 8.36% in the same timeframe. There is a notable rise in investor participation, with delivery volume increasing by 62.08% compared to the 5-day average, indicating some interest despite the overall downward trend. Broader Market Context: In the short term, Natraj Proteins has underperformed relative to the Sensex, which has gained 0.96% over the past week whil...
Read More
Natraj Proteins Q2 FY26: Mounting Losses Deepen as Operating Margins Turn Severely Negative
2025-11-18 17:00:00Natraj Proteins Ltd., a micro-cap edible oil manufacturer with a market capitalisation of ₹16.00 crores, reported a widening quarterly loss in Q2 FY26, posting a net loss of ₹1.65 crores compared to a loss of ₹1.21 crores in Q1 FY26. The sequential deterioration of 36.36% underscores the mounting operational challenges facing the Madhya Pradesh-based company, which has struggled to maintain profitability despite modest revenue growth. Year-on-year, the loss widened from ₹1.01 crores in Q2 FY25, representing a 63.37% deterioration in bottom-line performance.
Read More
Natraj Proteins Faces Financial Challenges Amidst Operational Efficiency Gains
2025-11-18 11:01:16Natraj Proteins, a microcap in the edible oil sector, reported a negative financial performance for the quarter ending September 2025, with declining net sales and low quarterly PBDIT. Despite achieving its highest operating cash flow, the company faces significant challenges, reflected in its stock performance compared to the Sensex.
Read MoreIs Natraj Proteins overvalued or undervalued?
2025-11-18 08:20:48As of 17 November 2025, the valuation grade for Natraj Proteins has moved from expensive to attractive, indicating a significant shift in its perceived value. The company is currently considered undervalued. Key ratios include a PE ratio of -9.07, an EV to EBITDA of 34.42, and a Price to Book Value of 0.49, which highlight its low valuation compared to earnings and assets. In comparison to peers, Gokul Agro has a PE ratio of 20.15 and an EV to EBITDA of 10.23, while Guj. Ambuja Exp shows a PE of 22.97 and an EV to EBITDA of 11.75, both of which are considerably higher than Natraj Proteins. This suggests that Natraj is trading at a discount relative to its peers in the edible oil industry. Despite recent underperformance against the Sensex, with a year-to-date return of -14.80% compared to the Sensex's 8.72%, the attractive valuation suggests potential for recovery and growth....
Read MoreHow has been the historical performance of Natraj Proteins?
2025-11-13 23:16:01Answer: The historical performance of Natraj Proteins shows significant fluctuations in key financial metrics over the years. Breakdown: Natraj Proteins experienced a decline in net sales from 193.73 Cr in Mar'24 to 117.78 Cr in Mar'25, following a trend of decreasing sales since Mar'23 when it was 143.60 Cr. The total operating income mirrored this decline, dropping to 117.78 Cr in Mar'25 from 193.73 Cr in Mar'24. Raw material costs also decreased significantly, falling from 150.82 Cr in Mar'24 to 95.70 Cr in Mar'25. Despite this reduction in costs, the operating profit (PBDIT) turned positive at 1.61 Cr in Mar'25 after being negative in Mar'24. However, the company reported a profit before tax of -1.18 Cr in Mar'25, indicating ongoing challenges. The profit after tax also remained negative at -1.46 Cr. The total liabilities decreased from 77.83 Cr in Mar'24 to 58.63 Cr in Mar'25, while total assets also ...
Read MoreIs Natraj Proteins overvalued or undervalued?
2025-10-17 08:03:51As of 16 October 2025, the valuation grade for Natraj Proteins has moved from expensive to very expensive, indicating a significant deterioration in its valuation outlook. The company is currently overvalued, with a PE ratio of -16.45, an EV to EBITDA of 25.34, and a Price to Book Value of 0.47. These metrics suggest that the company is not only struggling with profitability but also has a high valuation relative to its earnings potential. In comparison to its peers, Natraj Proteins stands out unfavorably; for instance, Gokul Agro has a PE ratio of 19.47 and an EV to EBITDA of 9.68, while Guj. Ambuja Exp boasts a PE of 20.65 and an EV to EBITDA of 11.15. The stark contrast in these ratios highlights Natraj's overvaluation in the edible oil sector. Additionally, the company's recent stock performance has lagged behind the Sensex, particularly over the past year, where it reported a return of -13.57% compare...
Read MoreIs Natraj Proteins overvalued or undervalued?
2025-10-15 08:04:21As of 14 October 2025, the valuation grade for Natraj Proteins has moved from very expensive to expensive, indicating a slight improvement in perceived value but still reflecting a high valuation relative to its fundamentals. The company is currently considered overvalued. Key ratios include a PE ratio of -16.48, an EV to EBITDA of 25.36, and a Price to Book Value of 0.48, which highlight significant concerns regarding profitability and valuation metrics. In comparison to peers, Gokul Agro has a fair valuation with a PE ratio of 19.6, while Guj. Ambuja Exp is rated attractive with a PE of 19.66. These comparisons suggest that Natraj Proteins is trading at a substantial premium despite its negative earnings, which is a notable outlier in the industry. Additionally, the company's stock has underperformed against the Sensex, with a year-to-date return of -8.30% compared to the Sensex's 4.98%, reinforcing the ...
Read MoreWhy is Natraj Proteins falling/rising?
2025-10-09 21:26:38As of 09-Oct, Natraj Proteins Ltd's stock price is currently at Rs 40.69, reflecting an increase of Rs 1.14 or 2.88%. Today, the stock has shown significant volatility, reaching an intraday high of Rs 42.9, which is an increase of 8.47%, while it also dipped to a low of Rs 38.21, marking a decrease of 3.39%. The stock has outperformed its sector by 3.75% today, although it has experienced a notable decline in delivery volume, which fell by 62.16% compared to the 5-day average. Over the past week, the stock has gained 4.33%, and over the past month, it has risen by 5.14%, despite a year-to-date decline of 8.77% and a one-year drop of 13.43%. In the broader market context, the Sensex has increased by 1.47% over the past week and 1.32% over the past month, indicating that Natraj Proteins' short-term performance is significantly better than the benchmark. However, the stock's year-to-date performance is laggin...
Read MoreWhy is Natraj Proteins falling/rising?
2025-10-07 21:29:29As of 07-Oct, Natraj Proteins Ltd is experiencing a price increase, currently at Rs 41.81, reflecting a rise of 2.66 or 6.79%. The stock opened with a significant gain of 9.58% today and reached an intraday high of Rs 44, indicating strong positive momentum. Despite this, the stock has shown a year-to-date decline of 6.26% and a one-year drop of 7.13%, suggesting that while there is a short-term uptick, the longer-term performance remains weak. Additionally, the stock has been trading above its moving averages across various time frames, which typically indicates bullish sentiment. However, there has been a notable decrease in investor participation, with delivery volume falling by 40.39% compared to the five-day average, which could temper the stock's upward movement. In the broader market context, Natraj Proteins' short-term performance over the past week shows a modest gain of 0.26%, which is underperfo...
Read MoreAnnouncement under Regulation 30 (LODR)-Newspaper Publication
14-Nov-2025 | Source : BSESubmission of Press clipping related to extract of Quarterly/ Half- yearly Unaudited Fiancial Result of the Company for the Quarter/ Half year ended 30th September 2025
Board Meeting Outcome for Outcome For The Board Meeting Held On 13/11/2025
13-Nov-2025 | Source : BSEWe are pleased to submit the Outcome of the Board Meeting held on 13/11/2025 for approval of the unaudited quarterly/half year financial statements for the quarter/half year ended on 30/09/2025 alongwith other routine matters.
Submissions Of Financial Results For The Quarter And Half Year Ended 30Th September 2025
13-Nov-2025 | Source : BSEPursuant to Regulation 33 of SEBI(LODR) 2015 we are pleased to submit the Financial Results for the Qaurter and Half Year ended 30th September 2025.
Corporate Actions
No Upcoming Board Meetings
No Dividend history available
No Splits history available
No Bonus history available
No Rights history available






